• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Nitrobenzoic acids and derivatives

Methyl 3-broMo-4-Methoxy-5-nitrobenzoate (CAS No. 40258-73-9): A Comprehensive Overview

Methyl 3-broMo-4-Methoxy-5-nitrobenzoate, identified by its CAS number 40258-73-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its unique structural motifs, exhibits a blend of chemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules. The presence of both bromine and nitro functional groups, along with methoxy substitution, imparts distinct reactivity and potential applications in drug development.

The compound's molecular structure, featuring a benzoate backbone with strategic functionalization, positions it as a versatile building block for the construction of more complex pharmacophores. In recent years, there has been growing interest in exploring the synthetic pathways and applications of such halogenated nitroaromatic compounds due to their role in modulating biological pathways and their potential as precursors for therapeutic agents.

One of the most compelling aspects of Methyl 3-broMo-4-Methoxy-5-nitrobenzoate is its utility in the synthesis of novel heterocyclic compounds. The bromine atom, in particular, serves as a reactive site for cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing biaryl structures prevalent in many modern drugs. Additionally, the nitro group can be reduced to an amine, providing another pathway for further functionalization and diversification of the molecular framework.

Recent studies have highlighted the importance of nitroaromatic compounds in medicinal chemistry due to their ability to interact with biological targets in unique ways. For instance, derivatives of this class of compounds have been investigated for their potential anti-inflammatory, antitumor, and antimicrobial properties. The methoxy group on Methyl 3-broMo-4-Methoxy-5-nitrobenzoate further enhances its versatility by allowing for selective modifications that can fine-tune the pharmacological profile of the resulting molecules.

In the context of drug discovery, the synthesis of Methyl 3-broMo-4-Methoxy-5-nitrobenzoate exemplifies the strategic use of functional group interconversions to develop libraries of compounds for high-throughput screening. The compound's structural features make it an attractive candidate for generating analogs with enhanced binding affinity and reduced toxicity. This approach aligns with the growing trend toward rational drug design, where computational modeling and synthetic chemistry are integrated to accelerate the discovery process.

The bromine substituent on Methyl 3-broMo-4-Methoxy-5-nitrobenzoate also opens up possibilities for further derivatization through metal-catalyzed reactions. For example, palladium-catalyzed borylation followed by Suzuki coupling can introduce aryl groups at various positions along the benzoate ring, leading to a diverse array of substituted derivatives. These reactions are highly regioselective and efficient, making them ideal for large-scale synthesis and industrial applications.

Moreover, the nitro group's ability to undergo reduction to an amine provides a straightforward route to amine-containing intermediates. Amines are fundamental building blocks in organic synthesis and are widely used in the preparation of peptides, amino acids, and other biologically active molecules. By leveraging this property, researchers can construct more complex structures that mimic natural products or designed ligands targeting specific biological pathways.

The methoxy group on Methyl 3-broMo-4-Methoxy-5-nitrobenzoate also plays a crucial role in influencing the electronic properties of the molecule. Methoxy substitution is known to electron-donating effects through resonance stabilization, which can modulate reactivity and interactions with biological targets. This feature is particularly valuable in designing molecules with optimized solubility and bioavailability—key factors in drug development.

In conclusion, Methyl 3-broMo-4-Methoxy-5-nitrobenzoate represents a promising compound in pharmaceutical research due to its versatile structural features and synthetic utility. Its ability to serve as a precursor for a wide range of bioactive molecules underscores its importance in medicinal chemistry. As research continues to uncover new applications for halogenated nitroaromatic compounds, Methyl 3-broMo-4-Methoxy-5-nitrobenzoate is poised to remain at the forefront of drug discovery efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)